ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Iterum hit by failure of anti-infective sulopenem
June 04, 2020Shares in Dublin, Ireland and Chicago, US-based Iterum Therapeutics have taken a hit on news that the firm's sulopenem did not achieve statistical non-inferiority relative to ertapenem in a trial in complicated urinary tract infection (cUTI). -
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections
July 19, 2019Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections. -
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections
July 18, 2019Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections. -
FDA Approves New Antibacterial Drug
August 31, 2017The U.S. Food and Drug Administration approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria.
Pharma Sources Insight January 2025
